Multicenter study on the effect of Mavacamten on pulmonary artery systolic pressure derived from echo-doppler in obstructive hypertrophic cardiomyopathy

Back

ESC2025 Premium Access

Multicenter study on the effect of Mavacamten on pulmonary artery systolic pressure derived from echo-doppler in obstructive hypertrophic cardiomyopathy

Session: Left ventricular outflow tract obstruction

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor M. Gegenava (Tbilisi, GE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Maka Gegenava

Tbilisi State Medical University (TSMU), Tbilisi (Georgia)

0 follower

6 more presentations in this session

Comparison of characteristics and outcomes of patients with obstructive vs. non-obstructive hypertrophic cardiomyopathy in a cohort from a referral center in colombia

Speaker: Doctor J. Orozco Burbano (Medellin, CO)

Outcomes of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in Japan

Speaker: Doctor T. Yamaguchi (Tokyo, JP)

Genetic, echocardiographic and clinical determinants of mitral valve abnormalities in hypertrophic cardiomyopathy

Speaker: Miss H. Panholzer (Graz, AT)

Common pathophysiological mechanism of SAM and mitral regurgitation in HOCM

Speaker: Associate Professor Z. Wang (Hangzhou, CN)

Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure (polypharmacy phenogroups and heart failure subgroups outcomes)

Speaker: Doctor A. Aboughalia (Doha, QA)

Access the full session

Left ventricular outflow tract obstruction

Speakers: Doctor M. Gegenava, Doctor J. Orozco Burbano, Doctor T. Yamaguchi, Miss H. Panholzer, Associate Professor Z. Wang...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources